ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
-3.49%
Brent Oil
79.395
-0.61%
Bitcoin
69,323.94
-2.04%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Omrix Biopharmaceuticals (MM) (OMRI)

  7. Omrix Biopharmaceuticals (MM) (OMRI) News

Omrix Biopharmaceuticals (MM) (OMRI)

Omrix Biopharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OMRI
DateTimeSourceHeadlineSymbolCompany
30/12/200822:21Edgar (US Regulatory)(25-NSE)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
30/12/200821:59Edgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities under Section 12(g) (15F-12G)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
30/12/200820:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
29/12/200814:57MarketwiredBridgewaterEquity.com Free Fundamental Sector & Market Research on BEBE, OMRI, SONS and CALMNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
29/12/200811:27Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
27/12/200815:08PR Newswire (US)Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200822:42PR Newswire (US)Johnson & Johnson Extends Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200822:00Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200821:49Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200811:02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
18/12/200821:02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
17/12/200822:24Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
17/12/200822:03Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
17/12/200811:04Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/12/200820:38Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/12/200822:40PR Newswire (US)Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
05/12/200821:52Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
03/12/200818:45MarketwiredLaw Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit on Behalf of Shareholders of Omrix Biopharmaceuticals, IncNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
01/12/200822:30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
01/12/200822:25Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
26/11/200811:01Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200822:12Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200818:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200817:43Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200817:38PR Newswire (US)Johnson & Johnson Begins Tender Offer to Acquire OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
24/11/200822:06Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
24/11/200811:30PR Newswire (US)Johnson & Johnson Announces Definitive Agreement to Acquire OmrixNASDAQ:OMRI
21/11/200816:03Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
10/11/200816:25Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
06/11/200818:47Business WireOmrix Biopharmaceuticals to Webcast Presentation at Credit Suisse Annual Healthcare ConferenceNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:OMRI

Your Recent History

USOTC
CYRB
Cyber App Solutions (PK)
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved